News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Clinical - Pre-Clinical
Shenyang Research Institute Selects Provantis Preclinical Software Solution For Chinese Drug Safety Evaluation Center 5/26/2016
GlycoMimetics, Inc. (GLYC) Announces Publication Of New Preclinical Data With GMI-1271 In Science Translational Medicine 5/26/2016
Viamet Receives Orphan Drug Designation From The FDA For VT-1598 For The Treatment Of Coccidioidomycosis 5/25/2016
Reviva Pharma Presented RP5063 Preclinical Efficacy Results For Pulmonary Arterial Hypertension At American Thoracic Society Conference 2016 5/20/2016
Regen BioPharma Announces ucVax: Universal Donor Cancer Cellular Immunotherapy 5/19/2016
Anavex (AVXL) Announces Positive Preclinical Data For ANAVEX 2-73 In Infantile Spasms 5/18/2016
Fate Therapeutics (FATE) Announces Preclinical Data Highlighting Persistent Effector Function Of Allogeneic Natural Killer Cell Cancer Immunotherapy 5/16/2016
TopiVert Completes TOP1630 Preclinical Development 5/16/2016
NovoCure To Present New Preclinical Data Showing Additive Efficacy Of Tumor Treating Fields And PD-1 Inhibitors At The American Association Of Immunologists’ Annual Meeting 2016 5/13/2016
Biostage Successfully Regenerates Esophagus In Groundbreaking Pre-Clinical Work With Mayo Clinic; Data Provides 'Proof Of Concept' To Seek FDA Approval For Clinical Trials 5/12/2016
Dicerna (DRNA) Reports Potent Preclinical Activity With GalNAc-DsiRNA-EX Conjugates 5/11/2016
IIT Research Institute Release: Zika Mouse Model Using Current Strain Enhances Quest For New Vaccines And Treatments 5/10/2016
IIT Research Institute Release: Zika Mouse Model Using Current Strain Enhances Quest For New Vaccines And Treatments 5/10/2016
Sangamo (SGMO) Presents Recent Developments From Research And ZFP Therapeutic Programs In Multiple Presentations At Annual Meeting Of The American Society Of Gene And Cell Therapy 5/9/2016
Dimension Therapeutics Announces Preclinical Data From Bayer-Partnered Hemophilia A Program At American Society For Gene And Cell Therapy (ASGCT) Annual Meeting 5/9/2016
uniQure (QURE) Presents Preclinical Data On AAV Re-Administration, Regulated Gene Expression And Total Brain Transduction At ASGCT 5/9/2016
GTx, Inc. (GTXI) Announces Presentation Of Preclinical Data Demonstrating The Ability Of Sards To Degrade And Inhibit The Androgen Receptor At The American Urological Association Annual Meeting 5/9/2016
Cytori Therapeutics (CYTX) Reports Preliminary Preclinical Data Supporting Use Of Cytori Cell Therapy For Both The Prevention And Treatment Of Hypertrophic Scars 5/5/2016
Relmada Therapeutics Announces Results Of In Vivo Study Showing d-Methadone Has Antidepressant-like Effects 5/4/2016
Acetylon Pharmaceuticals Publishes New Mechanism For The Treatment Of Sickle Cell Disease/Beta-Thalassemia With Selective HDAC1/2 Inhibition In Plos One 5/4/2016
Can-Fite BioPharma (CFBI) To Present Data On Cf602 In The Treatment Of Erectile Dysfunction At American Urological Association's Annual Meeting 5/2/2016
Eleven Biotherapeutics (EBIO) To Present Data At The Association for Research in Vision & Ophthalmology 2016 Annual Meeting 4/29/2016
ThromboGenics NV (TBGNF) Release: New Ocriplasmin Research Findings Presented At Upcoming Association for Research in Vision & Ophthalmology 2016 Annual Meeting In Seattle 4/27/2016
Exemplar Genetics Release: Game-Changing Animal Research Models Offer Superior Translational Research And Better Predictive Efficacy 4/27/2016
Independent Rat Study Finds 54% Oral Insulin Relative Bioavailability Using Tamarisk's MxBA Platform Technology 4/26/2016
NeuroVive (NVP) Starts Preclinical TBI Program In Collaboration With University of Pennsylvania 4/26/2016
Arbutus Biopharma (ABUS) Presents Data From Combination Activity Studies Of HBV Drug Candidates 4/22/2016
DelMar Pharma Release: FDA Grants Orphan Drug Designation For VAL-083 In Ovarian Cancer 4/21/2016
Merrimack (MACK) Unveils Its Latest Antibody Directed Nanotherapeutic, MM-310, At The 2016 AACR Annual Meeting 4/21/2016
Affimed (AFMD) Presents Data On AFM13-Mediated Innate/Adaptive Immune Crosstalk At The AACR Annual Meeting 2016 4/21/2016
PDS Life Sciences Now Proven Market Leader For SEND Submissions 4/21/2016
Affimed (AFMD) Presents Data On EGFRwt and EGFRvIII-Targeting NK- And T-Cell Tandabs At The AACR Annual Meeting 2016 4/21/2016
Peregrine (PPHM) Release: Preclinical Data Presented At AACR Annual Meeting Demonstrate Enhanced Therapeutic Benefit Of Combining A Ps-Targeting Antibody With Anti-Pd-1 Therapy In Models Of Triple Negative Breast Cancer (TNBC) 4/20/2016
CTI BioPharma Release: Preclinical Data Presented At AACR Indicate Pacritinib's Potential To Eradicate Therapy-Resistant Leukemia Stem Cells Residing In Bone Marrow Microenvironment 4/20/2016
Karyopharm (KPTI) Presents Data Demonstrating The Potential Of Nuclear Export Protein Exportin 1 (XPO1) Inhibition In The Treatment Of Traumatic Brain Injury 4/20/2016
Curis (CRIS) And Aurigene Discovery Technologies Limited Present Preclinical Data From Multiple Programs At AACR Annual Meeting 4/20/2016
Immune Design Corporation (IMDZ) Presents New Preclinical Data On Advances Of Two Separate Intratumoral Approaches At The AACR Annual Meeting 2016 4/20/2016
vTv Therapeutics Presents Data On Two Diabetes Candidates At Keystone Symposia On New Therapeutics For Diabetes And Obesity 4/20/2016
Syros Pharmaceuticals Presents New Data Demonstrating Significant Anti-Tumor Activity Of Its Selective CDK7 Inhibitor In Preclinical Models Of Acute Myeloid Leukemia 4/20/2016
Acetylon Pharmaceuticals Announces The Presentation Of Preclinical Data At AACR Supporting The Use Of Selective HDAC6 Inhibition To Modulate Chronic Lymphocytic Leukemia (CLL) Immunobiology 4/20/2016
Euclises Pharmaceuticals To Present Preclinical Efficacy Results At AACR 4/19/2016
Celsion (CLSN) Presents Compelling Data At AACR 2016 Demonstrating Synergistic Anti-Cancer Effect Of GEN-1 IL-12 Immunotherapy Plus Avastin And Doxil 4/19/2016
Halozyme (HALO) Expands Oncology Pipeline With Two Compounds Designed For Activity In The Tumor Microenvironment 4/19/2016
BioLineRx Announces Presentation Of Detailed Mechanism Of Action Data For Lead Oncology Platform At AACR 2016 4/19/2016
Tocagen Inc. Presents Positive Preclinical, Proof-Of-Mechanism Data At The AACR Annual Meeting 4/19/2016
Combinations Of Viralytics Ltd (VLA.AX) CAVATAK And Checkpoint Immunotherapy Demonstrate Anti-Cancer Activity In Preclinical Lung Cancer And Melanoma Studies 4/19/2016
TRANSGENE (ENX:TNG) Presents Pre-Clinical Data At AACR On A New Generation Oncolytic Viral Immunotherapy Armed With An Anti-PD1 Monoclonal Antibody 4/19/2016
Arrowhead Pharma (ARWR) Presents Preclinical Data On Renal Cell Carcinoma Program At AACR 2016 4/19/2016
Ariad (ARIA) Announces Results Of Preclinical Studies On AP32788 At The Annual Meeting Of AACR 4/19/2016
Infinity Pharmaceuticals Inc. (INFI) Release: IPI-549 Alters The Immune-Suppressive Microenvironment And Enhances The Activity Of Checkpoint Inhibitors In Preclinical Models 4/18/2016
Compugen Ltd. (CGEN) Achieves Preclinical Milestone In Cancer Immunotherapy Collaboration With Bayer (BAY) 4/18/2016
DelMar Pharma's VAL-083 Demonstrates Promise In The Treatment Of Non-Small Cell Lung Cancer And Ovarian Cancer 4/18/2016
Nektar Therapeutics (NKTR) Release: Preclinical Data Presented At AACR Demonstrate That Combining NKTR-214 With Checkpoint Blockade Is Superior To Dual Checkpoint Inhibition In Increasing Clonality Of The T Cell Receptor (TCR) Repertoire And T Cell Tumor Infiltration 4/18/2016
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present REOLYSIN Preclinical Research At The 2016 AACR Annual Meeting 4/18/2016
BerGenBio AS Presents New Data Demonstrating That BGB324 Enhances Checkpoint Inhibitor Blockade 4/18/2016
Tolero Pharmaceuticals Presents Data Demonstrating AXL Inhibition Leads To A Reversal Of A Mesenchymal Phenotype Sensitizing Cancer Cells To Targeted Agents And Immuno-Oncology Therapies 4/18/2016
Syros Pharmaceuticals Presents Data Demonstrating Significant Anti-Cancer Activity Of SY-1425 In Preclinical Models Of Acute Myeloid Leukemia 4/18/2016
Asana Biosciences To Provide First Presentation Of Pre-Clinical Data On Its Novel ERK 1/2 Inhibitor Program At The AACR Annual Meeting 4/15/2016
Kadmon To Present Preclinical Data Demonstrating That Its Novel Immuno-Oncology Compound Achieves Long-Lasting And Persistent Antitumor Immunity 4/15/2016
Clementia Release: Positive Effects Of Palovarotene On Spontaneous Heterotopic Ossification, Mobility, And Skeletal Growth In Mouse Models Of FOP Reported In Journal Of Bone And Mineral Research 4/14/2016
ProMetic Life Sci (PFSCF.PK) Confirms PBI-4050's Anti-Fibrotic Effect In Nash Model And On Human Hepatic Stellate Cells 4/14/2016
Arbutus Biopharma (ABUS) Presents Data On HBV Capsid Assembly Inhibitor AB-423 At EASL 2016 4/14/2016
Cytori Therapeutics (CYTX) To Present Preliminary Safety And Efficacy Preclinical Data At The 2016 American Burn Association Meeting 4/14/2016
Assembly Biosciences To Present Data At The International Liver Congress 2016 That Supports Advancing Its CpAM Candidates Into HBV Clinical Trials 4/13/2016
CohBar Announces Preclinical Proof-Of-Principle Publication For SHLP Mitochondrial-Derived Peptides And Their Role In Metabolic Regulation And Cell Viability 4/12/2016
Antegrin Therapeutics Announces Publication Of Preclinical Data In Pancreatic Fibrosis 4/12/2016
Can-Fite BioPharma (CFBI) Announces New Pre-Clinical Data For CF602 Demonstrating Statistically Significant Full Recovery From Erectile Dysfunction After A Single Dose 4/11/2016
NewPhase Successfully Completed Small Mammal Pre-Clinical Trials Of A Cancer Treatment That Transforms Cancer To A Treatable Chronic Ailment 4/11/2016
Curis (CRIS) Announces Presentation Of Preclinical Data From CUDC-907, CA-170 And PD-L1/TIM-3 Antagonist And CA-4948 Programs At AACR Annual Meeting 4/11/2016
Earth Science Tech Announces Positive Results From First Pre-Clinical Study On New Hampshire Participate #1 Of Dysfunctional Veterans With PTSD (Posttraumatic Stress Disorder) Using ETST High Grade Hemp CBD (Cannabidiol) 4/11/2016
Verseon (VSN.L) Presents Further Trial Data On The Low Bleeding Risk Of Its Family Of Preclinical Anti-Coagulant Drugs At BioEurope Conference 4/11/2016
NovoCure To Present New Preclinical Data On Tumor Treating Fields At AACR Annual Meeting 2016 4/7/2016
EnGeneIC Pty Ltd Announces Publication Of Late-Stage Canine Brain Cancer Study Results In PLOS ONE 4/7/2016
Can-Fite BioPharma (CFBI) Reports 2015 Financial Results & Provides Clinical Pipeline Update 4/1/2016
Arbutus Biopharma (ABUS) To Present Preclinical HBV Data At EASL 2016 3/31/2016
Atreca Announces Presentation Of Preclinical Data For Antibody Discovery Program 3/31/2016
Theranexus: Preclinical Results Published In The Specialist Medical Journal Sleep 3/30/2016
Ironwood (IRWD) To Present Clinical And Preclinical Data On sGC Stimulators At Upcoming Scientific Conferences 3/30/2016
Galmed Pharmaceuticals Release: Aramchol Demonstrates Significant Anti-Fibrotic Effect In A Pre-Clinical Model Of Fatty Liver Disease 3/30/2016
Cincinnati Children's Hospital Medical Center Release: New Mouse Model for Acute Myeloid Leukemia Opens Door To Research, Possible Treatments 3/30/2016
Discarded GlaxoSmithKline (GSK) Drug Fights Two Disease-Causing Viruses In Lab 3/29/2016
ContraVir's CMX157 Bests Gilead (GILD)'s Tenofovir AF (TAF) Against Hep B Virus in Head-to-Head In-Vitro Study 3/29/2016
Soligenix (SNGX) Announces Publication Of Preclinical Efficacy Results With Dusquetide In Infectious Disease 3/29/2016
OWC Pharmaceutical Research Corp. Advances Its Multiple Myeloma Study To Animals 3/29/2016
Kolltan Pharmaceuticals Inc. To Present Preclinical Data At The 2016 AACR Annual Meeting 3/28/2016
Preclinical Efficacy Data Of Apogenix' APG101 In Myelodysplastic Syndromes (MDS) Published In Oncotarget 3/24/2016
uniQure (QURE) Announces Preclinical Proof Of Concept For Gene Therapy Approach In Huntington's Disease 3/23/2016
RaNA Therapeutics Presents Data On Advances In RNA Therapy Targeting Spinal Muscular Atrophy 3/23/2016
BioCad Release: Innovative Russian Medicine Mobilizes Human Immune System To Fight Cancer 3/23/2016
Immune Pharma Announces Publication Of Preclinical Data In Support Of Its Bispecific Antibody Platform In The Journal Of Immunology 3/22/2016
uniQure (QURE) Announces Preclinical Proof Of Concept For Gene Therapy Approach In Huntington's Disease 3/22/2016
CytRx (CYTR) To Present New Data Using Its Proprietary LADR Technology At The 2016 AACR Annual Meeting 3/22/2016
Deciphera Announces Study Results For Altiratinib Demonstrating Inhibition Of Tumor Growth And Invasiveness In Glioblastoma 3/21/2016
Millendo Therapeutics Announces Publication Of Preclinical Data For ATR-101 And Data Presentations At ENDO 2016 3/21/2016
Ethris Publishes Preclinical Data On Musculoskeletal Regeneration Using Its Novel MRNA-Based Transcript Therapy Approach 3/21/2016
Lycera Announces Presentations Of Positive Preclinical Results For Lead Candidate LYC-30937 And For Selective Rho Kinase Inhibitor Program At The 11th Congress Of The European Crohn's And Colitis Organization (ECCO) 3/18/2016
Theravance Biopharma (TBPH) Presents Positive Results From A Preclinical Colitis Model For TD-1473, A GI-Targeted Pan-Janus Kinase (JAK) Inhibitor 3/18/2016
Celsion (CLSN) Announces Presentation Of Preclinical Data For GEN-1 IL-12 Immunotherapy In Combination With Avastin And Doxil At The AACR Annual Meeting 2016 3/17/2016
Blueprint Medicines (BPMC) To Present Preclinical Data On RET Inhibitors In An Oral Presentation At AACR Annual Meeting 3/17/2016
Halozyme (HALO) To Present Data From Five Preclinical Studies At AACR Annual Conference 3/17/2016
Syros Pharmaceuticals To Present Preclinical Data On SY-1425 And CDK7 Inhibitor Program In Blood Cancers At Upcoming AACR Annual Meeting 3/17/2016
GlycoMimetics, Inc. (GLYC) To Present New Preclinical Data On Its E-Selectin-CXCR4 Dual Antagonist At AACR Annual Meeting 2016 3/17/2016
Atreca Announces Presentation Of Preclinical Data For Cancer Immunotherapy Program 3/14/2016
Splenda Reduces Cancer Rates In Some Mice 3/10/2016
Organovo (ONVO) And Its Customers Present Data Supporting 3D Bioprinted Liver Tissues For Drug Toxicity Testing And Liver Fibrosis Modeling 3/10/2016
Neurotrope Announces Publication Demonstrating Synaptic Regeneration With The PKC Epsilon Activator Bryostatin, In A Fragile X Disease Late Brain Development Model 3/8/2016
GeoVax Labs Inc. (GOVX.OB) Release: Strong Protection Elicited By An Immunodeficiency Virus Vaccine In Non-Human Primates 3/8/2016
Benitec (BLT.AX)'s Hepatitis B Therapy Reduces HBV DNA By 98.5% in Early Study 3/8/2016
Biocryst (BCRX)'s Zika Drug Shows Promise In Mice 3/7/2016
Vaxart, Inc. Begins Preclinical Testing Of An Oral Zika Virus Vaccine 3/3/2016
Intensity Therapeutics, Inc. Reports Anti-Cancer Immunological Effect Generated By INT230-6 3/3/2016
Sangamo (SGMO) Presents New Data From In Vivo Protein Replacement Platform Programs For MPS I And MPS II At The 12th Annual WORLDSymposium Meeting 3/2/2016
Saronic Biotechnology Release: Dendritic Cell Vaccine Inhibits Tumor Progression In Preclinical Liver Cancer Model 2/26/2016
Kadmon To Present Preclinical Data Demonstrating ROCK2 Signaling As A Key Regulator Of T Follicular Helper Cell Function In Autoimmune Conditions 2/26/2016
NYU Langone Medical Center Release: ;Sleep Changes Seen With Fetal Alcohol Exposure Partly Explain Lifelong Learning And Mood Problems 2/25/2016
Anavex (AVXL) Presents Preclinical Results Of ANAVEX 2-73 In Rett Syndrome 2/25/2016
Regen BioPharma Completes Preclinical Experimentation For Its siRNA NR2F6 Checkpoint Inhibitor 2/24/2016
Gilead (GILD) Announces Data From New Preclinical Study Evaluating An Investigational TLR7 Agonist In SIV-Infected Monkeys 2/24/2016
GTx, Inc. (GTXI) Announces Presentation Of Preclinical Data Demonstrating The Effect Of GTx SARMs On Pelvic Floor Muscle Loss At The Society Of Urodynamics, Female Pelvic Medicine And Urogenital Reconstruction (SUFU) Meeting 2/24/2016
Summit Therapeutics Announces Publication Of Preclinical Data Showing Ridinilazole Outperformed Standard Of Care In Reducing C. Difficile Toxins That Drive Disease Symptoms 2/24/2016
Bone Therapeutics Presents ALLOB Pre-Clinical And Early Clinical Efficacy Data In Spinal Fusion At The "Clinical Applications Of Stem Cells" Conference 2/24/2016
Tamir Biotechnology, Inc. (Formerly Known as Alfacell Corporation) (ACEL) Release: Ranpirnase Exhibits Anti-Zika Activity 2/22/2016
Fate Therapeutics (FATE) To Present Preclinical Data For Protmune At 2016 BMT Tandem Meetings 2/22/2016
vTv Therapeutics Reports Preclinical And Clinical Results On Its Diabetes Candidate TTP273 2/22/2016
Inovio Pharma (INO)'s DNA Vaccine For Zika Virus Induces Robust Immune Responses In Preclinical Study 2/17/2016
Verseon (VSN.L) To Unveil New Preclinical Results For Novel Class Of Oral Anticoagulants At The 3rd International Conference On Heart & Brain 2/10/2016
Oncotelic Presents The Synergy Of OT-101 (A Late Stage TGF beta inhibitor) And A Chemotherapy Agent 2/9/2016
Amgen (AMGN) Releases Secret Data on Three Failed Studies to Confirm Findings in High Profile Journals 2/5/2016
Can-Fite BioPharma (CFBI) To Present At BIO CEO & Investor Conference In New York City On February 8, 2016 2/5/2016
Lamellar Biomedical Ltd Release: Visco-ease Paper Published In Supportive Care Journal 2/2/2016
NewLink Genetics (NLNK) Announces Project To Develop New Treatment Options For The Zika Virus 2/2/2016
Goodwin Biotechnology, Inc. Teams With Panacea Pharmaceuticals, Inc. In Overcoming A Significant Bioconjugation Challenge For An Anti-Cancer Monoclonal Antibody 2/1/2016
Bio-Path Holdings, Inc. (BPTH) To Present At The 18th Annual BIO CEO & Investor Conference 2/1/2016
Nektar Therapeutics (NKTR) Publishes Pre-Clinical Results For NKTR-214, An Investigational CD122-Biased Immune-Stimulatory Cytokine For The Treatment Of Cancer In Clinical Cancer Research 2/1/2016
NYU Langone Medical Center Release: Model of Viral Infection During Pregnancy Caused Autism-Like Behaviors In Mice By Triggering Key Immune Reaction 1/29/2016
Allergan (AGN) Release: Rapastinel (GLYX-13) Shown To Improve Ketamine Or PCP-Induced Cognitive Impairment In Mice 1/19/2016
Cerecor Inc. Announces Publication Describing Antidepressant Activity Of CERC-301 In Preclinical Model 1/19/2016
Adamas Pharmaceuticals (ADMS) Provides Review Of 2015 And Projected Future Milestones 1/13/2016
PsychoGenics Inc. And The Alzheimer's Drug Discovery Foundation Announce A Risk-Sharing Partnership For Preclinical Studies 1/12/2016
Kadmon To Present Preclinical Data Demonstrating The Importance Of ROCK2 Signaling In Modulating Immune Response 1/12/2016
NeuralStem Inc.'s Preclinical Alzheimer's Disease Data Published In Stem Cells Translational Medicine 1/11/2016
Kolltan Pharmaceuticals Inc. Provides Update On Clinical Pipeline, Corporate Developments And Near-Term Milestones 1/8/2016
AGTC (AGTC) Announces Preclinical Data Evaluating Cone-Specific Promoters For Use In Gene Therapy Of Achromatopsia And Other Retinal Diseases 1/7/2016
Glide Technologies Announces Successful Proof-Of-Concept With Novel Exenatide Solid Dose Formulation 1/6/2016
Akari Therapeutics Announces Additional Data From Non-Human Primate Safety Study Demonstrating Equivalent Coversin Efficacy In Both Elisa CH50 And Hemolytic SRBC Assays 1/5/2016
AiCuris' AIC649 Shows Potential To Induce Functional Cure Of Chronic Hepatitis B In Preclinical Study 1/5/2016
NYU Langone Medical Center Release: New Paste Prevents Scarring Caused By Radiation Therapy For Cancer 1/4/2016
Allen Institute for Brain Science Release: Using Genes To Understand The Brain's Building Blocks 1/4/2016
Araim Pharmaeuticals' ARA 290 Significantly Improves Islet Cell Function Following Islet Cell Transplantation In A Model Of Type 1 Diabetes 12/22/2015
Preclinical Validation Of Oncodesign SA’s First Radiotracer Prior To Human Application 12/17/2015
Longevity Biotech Release: Pioneering Neuroprotective Results Achieved In Parkinson's Disease Preclinical Studies 12/16/2015
AstraZeneca PLC (AZN)'s New R&D Approach Involves Diving into the Secretome 12/14/2015
Rexahn Pharmaceuticals, Inc. (RNN) Announces New Data For Supinoxin Showing Potent Tumor Growth Inhibition 12/14/2015
NovaTarg Therapeutics Aims to Reveal First Drug Candidates for Type 2 Diabetes, Kidney Disease in 2016 12/10/2015
Clinical Study Shows Assembly Biosciences' Oral Gemicel Technology Can Achieve Targeted Delivery To The Lower GI Tract For Microbiome And Other Applications 12/9/2015
NantKwest Announces Presentation Of Preclinical Data Of HER2.taNK At The San Antonio Breast Cancer Symposium (SABCS) 12/9/2015
Spring Bank Pharmaceuticals, Inc. Reports Preclinical Data On The Use Of SB 9200 With Entecavir In The Woodchuck Model Of HBV 12/8/2015
Immune Design Corporation (IMDZ) Highlights G100 Preclinical Data Demonstrating Direct And Abscopal Tumor Regression, Long-Term Response And Synergy With Checkpoint Blockade 12/8/2015
Imago Biosciences Announces Preclinical Data On LSD1 Inhibitor At Annual Meeting Of The American Society of Hematology 12/7/2015
Benitec (BLT.AX)'s Hepatitis B Therapeutic Shows Positive Preclinical Results 12/7/2015
Viking Therapeutics (VKTX) Presents New Data On VK5211 Demonstrating Robust Weight Gain In Primates Following 13 Weeks Of Treatment 12/7/2015
Achillion (ACHN) Announces Upcoming Oral Presentation At The 57th Annual Meeting Of The American Society of Hematology And Nomination Of ACH-4471, A Novel Small Molecule Factor D Inhibitor, For Clinical Development 12/7/2015
Acetylon Pharmaceuticals Presents Data On The Pharmacokinetics And Hbe/Hbg Hemoglobin Induction Following Once Daily Dosing Of An Oral HDAC1,2 Inhibitor In Animal Models 12/7/2015
GlycoMimetics, Inc. (GLYC) Presents Preclinical Data At American Society of Hematology Annual Meeting Showing GMI-1359 Enhances Efficacy Of Chemotherapy In FLT-3 AML Model 12/7/2015
Tolero Pharmaceuticals Presents Data Demonstrating Inhibition Of AXL Kinase In Cancer Cells Restores Drug Sensitivity Through A Mechanism Involving Retinoic Acid Signaling 12/7/2015
Tolero Pharmaceuticals Presents Preclinical Data Demonstrating Synergistic Activity With A Combination Of Alvocidib And Azacytidine 12/7/2015
Tolero Pharmaceuticals Presents Positive Preclinical Data On Hepcidin Inhibition For The Treatment Of Anemia Associated With Chronic Disease 12/7/2015
GlycoMimetics, Inc. (GLYC) Highlights Preclinical Data In Oral Presentation At American Society of Hematology Meeting Demonstrating Impact Of GMI-1271 On T Memory Stem Cells 12/7/2015
ADC Therapeutics Announces Positive Pre-clinical Results For Two Of Its Novel Adcs At The American Society of Hematology Conference 12/7/2015
Syros Pharmaceuticals Presents New Preclinical Data Demonstrating Significant Anti-Tumor Activity Of First-In-Class Selective CDK7 Inhibitor In Models Of Acute Leukemias 12/7/2015
bluebird bio (BLUE) Presents Pre-Clinical And Manufacturing Data From CAR T Oncology Programs At American Society of Hematology Annual Meeting 12/7/2015
Partikula Reports Positive Results From A Multi-Checkpoint Protein Inhibition Study Of Its First-In-Class Precision Tumor Microenvironment Modifiers (Tmem™) 12/4/2015
Ohr Pharma (OHRP) Announces Positive Preclinical Data In SKS Sustained Release Ocular Program 12/3/2015
Ocata’s Hemangio-Derived Mesenchymal Cells Preserve Kidney Function And Extend Lifespan In Preclinical Model Of Lupus Nephritis 12/3/2015
Hillhurst Biopharmaceuticals Receives SBIR Funding For Development Of HBI-002 As A Cytoprotective Therapeutic In Acute Cerebral Injury 12/2/2015
NanoBio Corporation's Chlamydia Vaccine Improves Clearance Of Bacteria And Prevents Pelvic Inflammatory Disease In Mice 12/2/2015
Arch Therapeutics Reports Significant Wound Healing Results in Pre-Clinical Safety Study With AC5 Surgical Hemostatic Device 12/2/2015
Topical Administration Of Cytori Therapeutics, Inc. (CYTX) Cell Therapy Effective In Thermal Burn Approach 11/30/2015
Anavex (AVXL) Release: Independent Research Describes ANAVEX 3-71 As Potent Cognitive Enhancer In Alzheimer's Disease Models 11/30/2015
BioLineRx Ltd. To Host Investor Breakfast In New York On December 3, 2015 11/25/2015
CTI BioPharma Announces Presentation Of Preclinical Data Demonstrating Potential Synergistic Combination Of Pacritinib And An EGFR Inhibitor In Targeting Brain Tumor Initiating Cells 11/23/2015
Can-Fite BioPharma (CFBI) Announces Compelling Pre-Clinical Data On CF102 In The Treatment Of Non-Alcoholic Steatohepatitis (NASH) 11/23/2015
Tocagen Inc. Presents Interim Data From Studies Evaluating Toca 511 & Toca FC At The Annual Meeting Of The Society For Neuro-Oncology (SNO) 11/23/2015
Athersys (ATHX)' MultiStem Promotes Recovery After Acute Spinal Cord Injury In Preclinical Study 11/19/2015
Memgen Announces Preclinical Results For Its ISF35 Cancer Immunotherapy With Checkpoint Inhibitors In Metastatic Melanoma 11/18/2015
DBV Tech To Present Preclinical Data On Its Viaskin Technology For RSV Vaccination At The 2015 RSV Vaccines For The World Meeting 11/18/2015
Profectus BioSciences, Inc. Presents Preclinical Data Demonstrating That A Single Dose Of Multi-Component Vaccine Provides Complete Protection Against Zaire And Sudan Species Of Ebola Virus And Marburg Virus 11/17/2015
MGB Biopharma Limited Successfully Completes Feasibility Study With Topical Formulation Of Its Lead Antibacterial MGB-BP-3 11/17/2015
Calithera Biosciences, Inc. (CALA) Presents Preclinical Study Findings For CB-839 At The 2015 Novel Cancer Therapeutics Summit 11/17/2015
Regen BioPharma Submits Response To FDA Questions On Hemaxellerate Investigational New Drug Application 11/17/2015
Regen BioPharma Initiates NR2F6 T Cell Immunotherapy Preclinical Program With Dr. Santosh Kesari, Director Of Neuro-Oncology At John Wayne Cancer Institute 11/12/2015
Blueprint Medicines (BPMC) To Present Preclinical Data At 2015 American Society of Hematology Annual Meeting Demonstrating Anti-Tumor Activity Of BLU-285 In A Model Of Acute Myeloid Leukemia 11/12/2015
ImmunoCellular Therapeutics, Ltd (IMUC) Enters Into Sponsored Research Agreement With University of Texas MD Anderson Cancer Center To Advance Stem-To-T-Cell Program 11/12/2015
Novogen Limited (NVGN) Release: Preclinical Studies Justify Mode Of Delivery And Dosing Regimen For Anisina 11/11/2015
Protalex, Inc. (PRTX) Announces Presentation Of Preclinical Data With PRTX-100 Supporting Treatment Of Immune Thrombocytopenia At The American Society of Hematology 57th Annual Meeting And Exposition 11/11/2015
Opexa Therapeutics (OPXA) Announces Supportive Preclinical Study Results For Its Neuromyelitis Optica (NMO) Program 11/11/2015
PHARNEXT's Pleodrug PXT-864 Demonstrates Positive Effects In Parkinson's Disease Preclinical Data Published In Nature's Scientific Reports 11/10/2015
Blueprint Medicines (BPMC) Highlights Advances In Preclinical Discovery Efforts 11/10/2015
Threshold Pharmaceuticals, Inc. (THLD) Release: Preclinical Studies Find That Tarloxotinib May Overcome Resistance To EGFR Tyrosine Kinase Inhibitors 11/10/2015
Calithera Biosciences, Inc. (CALA) Presents Preclinical Study Findings For CB-839 At The 2015 Novel Cancer Therapeutics Summit 11/10/2015